Postulated biogenesis of WS9885B and progress toward an enantioselective synthesis

Org Lett. 1999 Aug 26;1(4):645-8. doi: 10.1021/ol990723r.

Abstract

[formula: see text] WS9885B promotes the assembly of microtubules in vitro and displays cytotoxicity as potent as paclitaxel against several cancer cell lines. In this Letter, we propose a biogenesis for this architecturally complex bacterial metabolite from a much simpler, polyunsaturated precursor. We also present significant progress toward a convergent, enantioselective synthesis of WS9885B. Our work features a chemoselective palladium-catalyzed cross-coupling of two advanced building blocks and an uncommon Claisen-like cyclization.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antibiotics, Antineoplastic / chemical synthesis*
  • Catalysis
  • Cyclization
  • Heterocyclic Compounds, 4 or More Rings / chemical synthesis*
  • Palladium
  • Stereoisomerism
  • Streptomyces / chemistry

Substances

  • Antibiotics, Antineoplastic
  • Heterocyclic Compounds, 4 or More Rings
  • WS 9885B
  • Palladium